Results

Total Results: 434 records

Showing results for "end stage renal".

  1. Layout 1 (pdf file)

    digital.ahrq.gov/sites/default/files/docs/page/HIT%20Health%20Info%20rural_0.pdf
    February 01, 2010 - security or confidentiality issues; not finding a system that meets practice or department needs; end-user … Guided medication dosing for inpatients with renal insufficiency.
  2. digital.ahrq.gov/sites/default/files/docs/lesson/10-0047-ef-rural.pdf
    February 01, 2010 - security or confidentiality issues; not finding a system that meets practice or department needs; end-user … Guided medication dosing for inpatients with renal insufficiency.
  3. www.ahrq.gov/patient-safety/settings/esrd/resource/dialysis-fistula.html
    April 01, 2014 - Initiating Dialysis With Fistula or Graft: Accessing Medication Port To Administer Medication This video vignette illustrates proper initiation of dialysis for patients with fistulae or grafts and the way to properly administer medication. It can be shared with staff as a refresher on current practices and guid…
  4. hcup-us.ahrq.gov/db/nation/nis/APS-DRGsDefManualV25Public.pdf
    June 01, 2009 - such as significant acute diseases, acute exacerbations of significant chronic diseases, advanced or endstage chronic diseases, and chronic diseases associated with extensive debility. … KIDNEY & URIN TRCT NEOPL 675 673 OTH KIDNEY & URIN TRCT NEOPL 682 682 RENAL … FAILURE 683 682 RENAL FAILURE 684 682 … RENAL FAILURE 685 685 ADMIT FOR RENAL DIALYSIS 686
  5. digital.ahrq.gov/sites/default/files/docs/citation/r21hs024124-meguid-final-report-2018.pdf
    January 01, 2018 - complications from 18 to 6 by grouping similar complications together (infectious, pulmonary, cardiovascular, renal … FG s met at both the beginning and towards the end of the study period to evaluate SURPAS … consensus about particular topics discussed in FGs to develop a matrix analysis.(25) The synthesis stage … seven outcomes (0.893 for pulmonary, 0.875 for bleeding/transfusion, 0.871 for cardiac, 0.863 for renal
  6. www.ahrq.gov/sites/default/files/wysiwyg/chsp/compendium/2018-Compendium-TechDoc-update.pdf
    January 01, 2018 - models Model Name Type Scope Medicare Shared Savings Program Accountable care National Comprehensive End-StageRenal Disease Care Model Accountable care National Next Generation ACO Modela Accountable care … with a health system that participated in a Medicare Shared Savings Program ACO, a Comprehensive End-StageRenal Disease Care Model ACO, or a Next Generation ACO Number of physicians participating in a … The list reflects health systems in the United States at the end of 2018.
  7. hcup-us.ahrq.gov/db/nation/nis/reports/NIS_2012_Redesign_report.jsp
    January 01, 2012 - More than 50 percent of AHA respondents report statistics for fiscal years, which often end in June or … More than 50 percent of AHA respondents report statistics for fiscal years, which often end in June or … We address this further in our conclusions at the end of this report. … present, (1) Comorbidity is present Keep CM_RENLFAIL 2002-2011 AHRQ comorbidity measure: Renal … Disease Staging: Principal Disease Category N/A DS_Stage1 2002-2010 Disease Staging: Stage
  8. www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary4/colorectal-cancer-screening-2008
    October 15, 2008 - solid organ masses or chest nodules, abdominal aortic aneurysms ≥3 cm, aneurysms of the splenic or renal … populations. 49 , 65-67 , 69 , 70 Extracolonic findings of moderate clinical significance (such as renal … Cancer of the colon and rectum in California: trends in incidence by race/ethnicity, stage, and subsite … Incidence of colorectal carcinoma in the U.S.: an update of trends by gender, race, age, subsite, and stage … [PMID: 15061598] Surveillance, Epidemiology, and End Results Program.
  9. www.ahrq.gov/patient-safety/settings/esrd/resource/clinicalcare.html
    January 01, 2015 - Clinical Care ESRD Toolkit The Clinical Care module of the ESRD Toolkit summarizes why proper clinical care is important in preventing vascular access infections, explains practices staff members can follow during site access to reduce infection risk, and describes ways to evaluate infection control practices…
  10. www.ahrq.gov/patient-safety/settings/esrd/resource/checklist.html
    January 01, 2015 - Using Checklists and Audit Tools ESRD Toolkit The Using Checklists and Audit Tools module of the ESRD Toolkit explains the importance of using data in the quality assurance and performance improvement process, and explains how implementing checklists and audit tools aligns with the principles of safe design. …
  11. www.ahrq.gov/patient-safety/settings/esrd/resource/tooluse.html
    October 01, 2020 - How To Use the ESRD Toolkit ESRD Toolkit The toolkit consists of four instructional modules that a facilitator can use to teach dialysis center team members specific ways to create a culture of safety. The modules are modifiable to meet individual dialysis center training needs. Modules of the ESRD Toolkit …
  12. www.ahrq.gov/patient-safety/settings/esrd/resource/cultureofsafety.html
    January 01, 2015 - Creating a Culture of Safety ESRD Toolkit The Creating a Culture of Safety module of the ESRD Toolkit discusses the importance of a comprehensive, unit-based approach to safety and its impact on improving patient care and reducing harm in dialysis centers. Presentation Slides ( PPTX, 20 M B) Facilitator …
  13. www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary29/hepatitis-b-virus-infection-screening-nonpregnant-adolescents-adults-may-2014
    May 27, 2014 - Changes in liver histology as a "surrogate" end point of antiviral therapy for chronic HBV can predict … Child–Pugh score, separately and in combination with spontaneous bacterial peritonitis with sepsis, renal … prospective or retrospective) Histologic response (improvement of ≥2 points on HAI score after end … all HBsAg clearance: 9.7% ALT level: NR AST level: NR HBV DNA level: NR Fibrosis stage … prospective or retrospective) Sustained biochemical response (normalization of ALT levels at the end
  14. www.uspreventiveservicestaskforce.org/home/getfilebytoken/sZN5HHS8w5Sar6bBPabsaB
    June 01, 2008 - Ann Intern Med. 2008;148:855-868. www.annals.org For author affiliations, see end of text. … English-language systematic reviews and stud- ies published between March 2001 (6 months before the end … need to be intensively treated for 10 years to prevent 1 person from developing any single clinical end … angio- tensin converting enzyme inhibitors and angiotensin II receptor antagonists on mortality and renal … life Cardiovascular morbidity Lower-extremity amputations Nonhealing ulcers Severe visual impairment Stage
  15. integrationacademy.ahrq.gov/sites/default/files/2021-04/Table_of_Opioid_and_Pain_Management_Tools_and_Resources.pdf
    January 01, 2021 - Stewardship and Safety in the ESRD Population Conference presentation discusses opioids in the end-stagerenal disease (ESRD).
  16. www.ahrq.gov/sites/default/files/wysiwyg/patient-safety/highlights/ps-project-highlights-medication-safety.pdf
    September 30, 2024 - By the end of 2008, researchers had planned to release a test collection of drug names and relevance … Similarly, data from the health literacy randomized trial was still being analyzed at the project’s end … system for updating patient contact information was in full flow and consistently carried out by the end … Key Findings/Impact: Each stage of the medication use process poses risks to oral chemotherapy safety … cognitive impairment, history of falls/hip fractures, heart failure, history of peptic ulcer disease, or stage
  17. 2014-04 (pdf file)

    hcup-us.ahrq.gov/reports/methods/2014-04.pdf
    January 01, 2014 -  More than 50 percent of AHA respondents report statistics for fiscal years, which often end in …  More than 50 percent of AHA respondents report statistics for fiscal years, which often end in … We address this further in our conclusions at the end of this report. … not present, (1) Comorbidity is present Keep CM_RENLFAIL 2002-2011 AHRQ comorbidity measure: Renal … 2002-2010 Disease Staging: Principal Disease Category N/A DS_Stage1 2002-2010 Disease Staging: Stage
  18. hcup-us.ahrq.gov/db/nation/nis/reports/NISRedesignFinalReport040914.pdf
    June 11, 2014 -  More than 50 percent of AHA respondents report statistics for fiscal years, which often end in …  More than 50 percent of AHA respondents report statistics for fiscal years, which often end in … We address this further in our conclusions at the end of this report. … not present, (1) Comorbidity is present Keep CM_RENLFAIL 2002-2011 AHRQ comorbidity measure: Renal … 2002-2010 Disease Staging: Principal Disease Category N/A DS_Stage1 2002-2010 Disease Staging: Stage
  19. www.uspreventiveservicestaskforce.org/home/getfilebytoken/o6pGCffkVCx24mNebJGCXg
    January 01, 2013 - Ann Intern Med. 2013;158:114-123. www.annals.org For author affiliations, see end of text. … refers to the cross- linking of polyethylene glycol molecules to the interferon molecule, which delays renal … intermediate out- come, was defined as the absence of detectable HCV RNA in the serum 6 months after the end … For regimens longer than 12 weeks, dual therapy was continued to the end of treatment. … adjusted hazard ratios, 0.12 to 0.46) (60, 62, 63, 67, 68, 71, 73–76, 78), and other complications of end-stage
  20. www.ahrq.gov/patient-safety/settings/esrd/resource/fostersafety.html
    April 01, 2014 - Fostering a Culture of Safety This video vignette shows a fictional scenario in which a positive culture of safety overcomes multiple commonly seen barriers to infection prevention in dialysis facilities. Fostering a Culture of Safety YouTube embedded video: https://www.youtube-nocookie.com/embed/TLeHkU34_…

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive